Note 3.1
(a) During the year the company has issued and alloted 97,26,458 equity shares of Rs.10 each as bonus share in the ratio of 7:1
(b) During the year the company has issued and alloted 42,84,000 equity shares of Rs.10 each at a premium of Rs.122 per share through initial public offer as per section 52 of companies act, 2013, aggregating to Rs 5654.88 lakhs.
c) Terms / rights attached to equity shares
1) The Company has only one class of equity shares having a par value of ?10 per equity share held.
2) Each share holder is eligible for one vote per share.
3) If any dividend is proposed by the Board of Directors than the same is subject to approval of the Shareholders in the ensuing annual general meeting except in case of interim dividend.
4) In the unlikely event of liquidation of the company the equity shareholders are eligible to receive the residual value of assets of the company if any after all secured and unsecured creditors of the company are paid off, in the proportion of their shareholding in the company.
Note 4.1. The net issue expenses of Rs 777.70 lakhs and premium for issuance of Bonus Shares of Rs 972.65 lakhs have been adjusted against securities premium.
4.2. As per transition provision of AS-15 “Employee Benefits”, the difference between transition liability is Rs. 18.15 lakhs (P.Y) is adjusted against reserves and surplus
32 Material events occuring after the date of Standalone Financial Statements.
In line with Accounting Standard 4, a wholly owned subsidiary “Unihealth Holdings Limited” of the company was incorporated in Mauritius on 07/05/2024
33 There are no transactions which were not recorded in books of accounts and have been surrendered or disclosed as income during the year in the tax assessments under Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961).
34 The company has not revalued Property, Plant and Equipment.
35 Loans or Advances in the nature of loans are granted to Related Parties (Subsidiaries- Biohealth limited, Unihealth Tanzania Limited & Unihealth Pharmaceutical Private Limited, Joint Venture- Victoria Hospital Limited & UMC Global Health Limited, Associate- Unihealth Uganda Limited) which are repayable in a single or in multiple tranches/ installments at any mutually agreed time within the tenure of the Loan as per the agreement entered with the Parties.
36 No proceedings have been initiated or pending against Company for holding any Benami Property under Prohibitions of Benami Transactions Act,1988 (Earlier titled as Benami Transactions (Prohibitions) Act,1988.
37 The Company has no borrowings from Banks or Financial Institutions
38 The Company has not been declared as willful defaulter.
39 During the year, the Company has not executed any transaction with Companies struck off under Section 248 of the Companies Act, 2013 or Section 560 of Companies Act, 1956.
40 No charges are pending for registration or satisfaction with the Registrar of Companies (ROC).
41 The Company is in compliance with the no. of layers as prescribed under clause (87) of section 2 of The Companies Act, 2013 read with the Companies (Restriction on Number of Layers) Rules, 2017.
42 (a) The Company has not advanced or loaned or invested funds, with any understanding, to any other person(s) or entity(ies),
including foreign entities (Intermediaries) that the Intermediary shall:
(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the company (Ultimate Beneficiaries) or
(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.
(B) The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:
(a) Directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or
(b) Provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
43 Corporate Social Responsibility -Section 135 of the Companies Act is not applicable to the Company.
Note 46
Previous year’s figures have been regrouped, rearranged or recasted to make them comparable wherever necessary.
|